Healthcare -
Biotechnology - NASDAQ - US
$ 3.1329
-8.39 %
$ 360 M
Market Cap
-3.37
P/E
ABSI - COST OF REVENUE
Cost of Revenue ABSI - Absci Corporation
47.6 M
LAST VALUE
167.37%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR